首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

2058268

疾病預防及控制疫苗市場：依產品類型、類型、給藥途徑、年齡層、適應症及地區分類。

Disease Control and Prevention Vaccine Market, By Product Type, By Type, By Route of Administration, By Age Group, By Indication, By Geography

出版日期: 2026年05月20日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，疾病預防控制疫苗市場規模將達到1,149億美元，到2033年將達到2,554億美元。預計2026年至2033年，該市場將以12.4%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	1149億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	12.40%	2033年市場規模預測：	2554億美元

疫苗是用於刺激抗體產生，進而活化免疫系統對抗流感、甲型肝炎、B型肝炎、人類乳突病毒、脊髓灰質炎和狂犬病等疾病的生物製藥。感染疾病的高發生率以及政府為實施全國免疫計劃而加大力度，預計將推動疫苗市場成長。另一方面，疫苗研發的高成本預計將阻礙疫苗市場成長。例如，根據美國疾病管制與預防中心 (CDC) 2015 年的報告，流感疫苗接種預防了約 190 萬例流感病例、96.6 萬例流感相關就診和約 6.7 萬例流感相關住院，相當於美國疾病負擔降低了 6.5%。

市場動態

預計在預測期內，全球疾病預防和控制疫苗市場將顯著成長，這主要得益於重組和細胞培養等新型疫苗研發技術的快速發展，進而帶動疫苗產量增加。例如，2018年，奧地利生技公司Themis Bioscience與總部位於奧斯陸的感染疾病防範創新聯盟（CEPI）建立了合作關係，CEPI將在五年內出資3750萬美元用於疫苗研發。此外，各國政府機構也支持研發項目，以開發現有疫苗的改良版本。例如，2015年，美國國家過敏症和感染疾病研究所（NIAID）的科學家開發了一種經過改造的蛋白質，該蛋白質能夠維持病毒刺突蛋白的特定形狀，從而刺激免疫系統產生強效的抗HIV抗體。然而，生產成本以及供需缺口導致的價格上漲預計將阻礙疾病預防和控制疫苗市場的成長。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球疾病預防和控制疫苗市場的主要參與者進行了分析：公司概況、財務業績、產品系列、地理分佈、分銷策略以及關鍵發展和策略。
透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、政府主導的舉措、技術升級、市場擴張和行銷策略做出明智的決策。
這份《全球疾病預防和控制疫苗市場》報告旨在為疾病預防和控制疫苗行業的眾多利益相關者提供參考，包括相關人員、產品製造商、經銷商、供應商、研究和諮詢公司、新參與企業和金融分析師。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 南非
- 中非
- 北非

第10章競爭格局

熱圖分析
公司簡介
- Pfizer Inc.
- GlaxoSmithKline plc
- Sanofi Pasteur
- Merck & Co., Inc.
- AstraZeneca PLC
- Johnson & Johnson
- Moderna, Inc.
- BioNTech SE
- Novavax, Inc.
- Sinovac Biotech Ltd.
- Serum Institute of India Pvt. Ltd.
- Bharat Biotech International Ltd.
- CSL Limited
- Dynavax Technologies Corporation
- Valneva SE Inovio Pharmaceuticals, Inc.
- Astellas Pharma Inc.
- Daiichi Sankyo Company, Limited
- Panacea Biotec Ltd.

第11章

參考
調查方法

簡介目錄

Product Code: CMI1500

Disease Control And Prevention Vaccine Market is estimated to be valued at USD 114.9 Bn in 2026 and is expected to reach USD 255.4 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 114.9 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	12.40%	2033 Value Projection:	USD 255.4 Bn

Vaccines are the biological preparation used for stimulating antibody production to activate immune system against diseases such as influenza, Hepatitis A, Hepatitis B, Human Papillomavirus, Polio, and Rabies. High prevalence of infectious disease and increasing governmental initiative for implementing nationalized vaccination programme are expected to drive growth of the vaccine market, whereas high developmental cost of vaccine is expected to hamper growth of the vaccine market. For instance, according to the Centers for Disease Control and Prevention (CDC), 2015, flu vaccinations prevented an around 1.9 million flu illnesses, 966,000 flu-associated medical visits, and around 67,000 flu-associated hospitalizations, representing 6.5% lowering of disease burden in the U.S.

Market Dynamics

The global disease control and prevention vaccine market is projected to witness significant growth over the forecast period, owing to rapid advancements in technology for development of novel vaccines such as recombinant and cell-based technologies, resulting in increasing production of the vaccines. For instance, in 2018, collaboration between Austrian biotech Themis Bioscience and Oslo-based Coalition for Epidemic Preparedness Innovations (CEIP). CEIP will fund US$ 37.5 million for vaccine development for five years. Moreover, governmental bodied supports the research and development program leading to the development of improved form of presently available vaccines. For instance, in 2015, a National Institute of Allergy and Infectious Disease scientists engineered a protein to maintain the specific shape of the viral spike, stimulating the immune system to produce powerful anti-HIV antibodies. However, manufacturing cost as well as large gap between demand and supply leading to hike in pricing is expected to hinder the growth of disease control and prevention vaccination market.

Key features of the study

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global disease control and prevention vaccine market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies
Key companies covered as a part of this study include GlaxoSmithKline plc (GSK), Merck & Co. Inc., Sanofi, AstraZeneca PLC, Pfizer, Inc., Serum Institute of India Pvt. Ltd., Sinovac Biotech Ltd., Astellas Pharma Inc., and Daiichi Sankyo
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion and marketing tactics.
The global disease control and prevention vaccine market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for disease control and prevention vaccine market, research and consulting firms, new entrants and financial analysts.

Market Segmentation

By Product Type (Revenue, USD Bn, 2021-2033)
- Live-attenuated Vaccines
- Inactivated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
By Type (Revenue, USD Bn, 2021-2033)
- Monovalent Vaccines
- Multivalent Vaccines
By Route of Administration (Revenue, USD Bn, 2021-2033)
- Oral
- Injectable
By Age Group (Revenue, USD Bn, 2021-2033)
- Pediatric Vaccines
- Adult Vaccines
By Indication (Revenue, USD Bn, 2021-2033)
- Infectious Diseases
- Cancer
- Other Indications
By Region (Revenue, USD Bn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
- Pfizer Inc.
- GlaxoSmithKline plc
- Sanofi Pasteur
- Merck & Co., Inc.
- AstraZeneca PLC
- Johnson & Johnson
- Moderna, Inc.
- BioNTech SE
- Novavax, Inc.
- Sinovac Biotech Ltd.
- Serum Institute of India Pvt. Ltd.
- Bharat Biotech International Ltd.
- CSL Limited
- Dynavax Technologies Corporation
- Valneva SE Inovio Pharmaceuticals, Inc.
- Vaxart, Inc.
- Astellas Pharma Inc.
- Daiichi Sankyo Company
- Limited and Panacea Biotec Ltd.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Type
- Market Snippet, By Route of Administration
- Market Snippet, By Age Group
- Market Snippet, By Indication
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Governmental Initiative
Product Pipeline
Regulatory Landscape
PEST Analysis
PORTER'S Five Forces

4. Global Disease Control and Prevention Vaccines Market, By Product Type, 2021-2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Live-attenuated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Inactivated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Recombinant Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Toxoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

5. Global Disease Control and Prevention Vaccines Market, By Type, 2021-2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Monovalent Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Multivalent Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

6. Global Disease Control and Prevention Vaccines Market, By Route of Administration, 2021-2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

7. Global Disease Control and Prevention Vaccines Market, By Age Group, 2021-2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Pediatric Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Adult Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

8. Global Disease Control and Prevention Vaccines Market, By Indication, 2021-2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
Other Indications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)

9. Global Disease Control and Prevention Vaccines Market, By Regions, 2021-2033, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, By Region, 2022-2033
- Regional Trends
North America
- U.S.
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Canada
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
Europe
- U.K.
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Germany
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Italy
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- France
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Spain
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Russia
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Rest of Europe
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
Asia Pacific
- China
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Japan
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- India
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- ASEAN
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Australia
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- South Korea
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Rest of Asia Pacific
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
Latin America
- Brazil
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Mexico
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Rest of Latin America
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
Africa
- North Africa
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Central Africa
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- South Africa
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
Middle East
- GCC Countries
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Israel
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)
- Rest of Middle East
  - Market Size and Forecast, By Product Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Type, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Route of Administration, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Age Group, 2021-2033, (US$ Billion)
  - Market Size and Forecast, By Indication, 2021-2033, (US$ Billion)

10. Competitive Landscape

Heat Map Analysis
Company Profiles
- Pfizer Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- GlaxoSmithKline plc
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Sanofi Pasteur
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Merck & Co., Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- AstraZeneca PLC
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Johnson & Johnson
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Moderna, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- BioNTech SE
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Novavax, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Sinovac Biotech Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Serum Institute of India Pvt. Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Bharat Biotech International Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- CSL Limited
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Dynavax Technologies Corporation
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Valneva SE Inovio Pharmaceuticals, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Astellas Pharma Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Daiichi Sankyo Company, Limited
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Panacea Biotec Ltd.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
  - Analyst Views